X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (97) 97
index medicus (90) 90
oncology (60) 60
female (55) 55
adult (47) 47
middle aged (47) 47
aged (46) 46
male (45) 45
cancer (28) 28
chemotherapy (24) 24
antineoplastic agents - therapeutic use (18) 18
combined modality therapy (14) 14
abridged index medicus (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
imatinib mesylate (13) 13
melanoma (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
prognosis (12) 12
aged, 80 and over (11) 11
follow-up studies (11) 11
gastrointestinal stromal tumors - drug therapy (11) 11
hematology (11) 11
phase-ii trial (11) 11
treatment outcome (11) 11
benzamides (10) 10
survival (10) 10
survival analysis (10) 10
survival rate (10) 10
antineoplastic agents - adverse effects (9) 9
neoplasm staging (9) 9
neoplasms - drug therapy (9) 9
piperazines - therapeutic use (9) 9
pyrimidines - therapeutic use (9) 9
antineoplastic agents - administration & dosage (8) 8
dose-response relationship, drug (8) 8
immunology (8) 8
life sciences (8) 8
lymphocytes (8) 8
melanoma - pathology (8) 8
cd8-positive t-lymphocytes - immunology (7) 7
chemotherapy, adjuvant (7) 7
colony-stimulating factor (7) 7
dacarbazine - analogs & derivatives (7) 7
disease-free survival (7) 7
drug administration schedule (7) 7
imatinib (7) 7
melanoma - drug therapy (7) 7
prognostic-factors (7) 7
radiotherapy (7) 7
stem-cell transplantation (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
cisplatin (6) 6
cisplatin - administration & dosage (6) 6
hematology, oncology and palliative medicine (6) 6
lung neoplasms - drug therapy (6) 6
medicine & public health (6) 6
melanoma - immunology (6) 6
melanoma - secondary (6) 6
melanoma - therapy (6) 6
metastasis (6) 6
neoplasm metastasis (6) 6
neoplasms (6) 6
oncology-group (6) 6
randomized-trial (6) 6
uveal melanoma (6) 6
young adult (6) 6
adolescent (5) 5
antigens (5) 5
clinical trials as topic (5) 5
efficacy (5) 5
europe (5) 5
gist (5) 5
in-vitro (5) 5
liver neoplasms - secondary (5) 5
medicine, research & experimental (5) 5
melanoma - genetics (5) 5
mutations (5) 5
pharmacokinetics (5) 5
phase-ii (5) 5
sarcoma - pathology (5) 5
sunitinib (5) 5
surgery (5) 5
therapy (5) 5
trial (5) 5
tumors (5) 5
tyrosine kinase (5) 5
uveal neoplasms - pathology (5) 5
analysis (4) 4
antigen (4) 4
antineoplastic agents - pharmacology (4) 4
antineoplastic agents, alkylating - administration & dosage (4) 4
antineoplastic agents, alkylating - adverse effects (4) 4
antineoplastic agents, alkylating - therapeutic use (4) 4
brain neoplasms - drug therapy (4) 4
brain neoplasms - mortality (4) 4
cancer-patients (4) 4
carcinoma (4) 4
care and treatment (4) 4
cells, cultured (4) 4
choroidal melanoma (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1782 - 1791
Journal Article
PLoS ONE, ISSN 1932-6203, 07/2015, Volume 10, Issue 7, pp. e0132977 - e0132977
Cancer stem cells are cancer cells characterized by stem cell properties and represent a small population of tumor cells that drives tumor development,... 
TESTIS ANTIGEN BORIS | HEPATOCELLULAR-CARCINOMA | SIDE POPULATION | IN-VITRO | INDUCED APOPTOSIS | TELOMERASE | MULTIDISCIPLINARY SCIENCES | IMPRINTED SITES | CTCF | IDENTIFICATION | TUMOR-INITIATING CELLS | ATP Binding Cassette Transporter, Sub-Family G, Member 2 | RNA, Small Interfering - genetics | Cell Proliferation | Epithelial Cells - metabolism | Polycomb Repressive Complex 1 - metabolism | Homeodomain Proteins - metabolism | Humans | Retinal Dehydrogenase - metabolism | Gene Expression Regulation, Neoplastic | Spheroids, Cellular - pathology | Epithelial-Mesenchymal Transition - genetics | Neoplasm Proteins - metabolism | SOXB1 Transcription Factors - metabolism | DNA-Binding Proteins - metabolism | Octamer Transcription Factor-3 - genetics | Polycomb Repressive Complex 1 - genetics | Telomerase - genetics | ATP-Binding Cassette Transporters - genetics | Neoplastic Stem Cells - metabolism | SOXB1 Transcription Factors - genetics | Isoenzymes - metabolism | Hyaluronan Receptors - metabolism | ATP-Binding Cassette Transporters - metabolism | Biomarkers, Tumor - metabolism | Neoplastic Stem Cells - pathology | Telomerase - metabolism | Neoplasm Proteins - genetics | DNA-Binding Proteins - antagonists & inhibitors | Nanog Homeobox Protein | Signal Transduction | Isoenzymes - genetics | Spheroids, Cellular - metabolism | Epithelial Cells - pathology | Retinal Dehydrogenase - genetics | DNA-Binding Proteins - genetics | Organ Specificity | Hyaluronan Receptors - genetics | Homeodomain Proteins - genetics | Phenotype | Octamer Transcription Factor-3 - metabolism | Cell Line, Tumor | Biomarkers, Tumor - genetics | Cell Movement | RNA, Small Interfering - metabolism | RNA | Genes | Colorectal cancer | Stem cells | Genetic aspects | Gene expression | Cancer | Protein binding | Neurosciences | Germ cells | Telomerase reverse transcriptase | Populations | Dyes | Mesenchyme | Oct-4 protein | Gene regulation | Oncology | Spheres | Drug resistance | Tissues | Metastases | DNA-binding protein | CD44 antigen | Cell cycle | Life sciences | Colon | Telomerase | Growth factors | Deoxyribonucleic acid--DNA | Medical research | Antigens | Cell survival | Tumor cells | Invasiveness | Cervix | Survival | Brain research | Molecular modelling | Medical prognosis | Epigenetics | Breast | Tumors | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 11/2016, Volume 99, Issue 5, pp. 1190 - 1198
Uveal melanoma (UM) is a rare intraocular tumor that, similar to cutaneous melanoma, originates from melanocytes. To gain insights into its genetics, we... 
OCULAR MELANOMA | CELLS | COLORECTAL-CANCER | PROTEINS DLK1 | METASTASES | GENETICS & HEREDITY | RISK | EXPRESSION | RADIATION | SF3B1 | SOMATIC MUTATIONS | Melanoma - diagnosis | Exons | Humans | Middle Aged | Male | Phosphoproteins - metabolism | Case-Control Studies | RNA Splicing Factors - metabolism | DNA Copy Number Variations | Melanoma - genetics | Melanocytes - pathology | Tumor Suppressor Proteins - genetics | Aged, 80 and over | Ubiquitin Thiolesterase - metabolism | Adult | Female | Membrane Proteins - metabolism | Eukaryotic Initiation Factor-1 - metabolism | GTP-Binding Protein alpha Subunits, Gq-G11 - metabolism | Tumor Suppressor p53-Binding Protein 1 - metabolism | GTP-Binding Protein alpha Subunits, Gq-G11 - genetics | Uveal Neoplasms - genetics | Genome-Wide Association Study | Tumor Suppressor Proteins - metabolism | GTP-Binding Protein alpha Subunits - metabolism | Tumor Suppressor p53-Binding Protein 1 - genetics | Membrane Proteins - genetics | Eukaryotic Initiation Factor-1 - genetics | Ubiquitin-Protein Ligases - metabolism | GTP-Binding Protein alpha Subunits - genetics | Phosphoproteins - genetics | RNA Splicing Factors - genetics | Ubiquitin Thiolesterase - genetics | Skin Neoplasms | Uveal Neoplasms - diagnosis | Aged | Mutation | Ubiquitin-Protein Ligases - genetics | Genetic aspects | Nucleotide sequencing | Methods | Melanoma | DNA sequencing | Metastasis | Pathogenesis | Genomics | Deoxyribonucleic acid--DNA | Index Medicus | Report
Journal Article
PloS one, ISSN 1932-6203, 2014, Volume 9, Issue 10, pp. e109921 - e109921
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 04/2018, Volume 124, Issue 7, pp. 1449 - 1454
Dasatinib produces high 18 F‐fluorodeoxyglucose‐positron emission tomography response rates in tyrosine kinase inhibitor‐naive patients with gastrointestinal... 
sunitinib | FDG‐PET | dasatinib | positron emission tomography (PET) | F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) | imatinib | gastrointestinal stromal tumor (GIST) | tyrosine kinase inhibitor (TKI) | PET | F-fluorodeoxyglucose-positron emission tomography (FDG-PET) | FDG-PET | SRC/ABL KINASE INHIBITOR | DOMAIN | TYROSINE KINASE | F-18-fluorodeoxyglucose-positron emission tomography (FDG-PET) | BMS-354825 | FOLLOW-UP | ABL | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | EARLY PREDICTION | IMATINIB MESYLATE | Prognosis | Follow-Up Studies | Gastrointestinal Neoplasms - drug therapy | Humans | Middle Aged | Dasatinib - therapeutic use | Gastrointestinal Stromal Tumors - diagnostic imaging | Male | Survival Rate | Antineoplastic Agents - therapeutic use | Gastrointestinal Neoplasms - pathology | Gastrointestinal Neoplasms - diagnostic imaging | Gastrointestinal Stromal Tumors - drug therapy | Gastrointestinal Stromal Tumors - pathology | Female | Radiopharmaceuticals | Positron Emission Tomography Computed Tomography - methods | BCR protein | Tyrosine | Imatinib | Toxicity | Emission analysis | Positron emission | Kinases | Patients | Survival | Metabolic response | Confidence intervals | Computed tomography | Surgery | Tomography | Positron emission tomography | Protein-tyrosine kinase | Cancer | Tumors
Journal Article
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2006, Volume 42, Issue 8, pp. 1093 - 1103
Journal Article